| HOME >> MEDICINE >> TECHNOLOGY |
STAAR Surgical CompanyCondensed Consolidated Statements of Operations(In 000's except for per share data)Three Months EndedSix Months Ended% ofJune 29,% ofJuly 1,Change% ofJune 29,% ofJuly 1,ChangeSales2012Sales2011Amount%Sales2012Sales2011Amount%Net sales100.0%
$ 15,942100.0%
$ 16,269$
(327)-2.0%100.0%
$ 31,451100.0%
$ 31,118$
3331.1%Cost of sales30.7%
4,89733.2%
5,408511-9.4%30.2%
9,50434.2%
10,6281,124-10.6%Gross profit69.3%
11,04566.8%
10,8611841.7%69.8%
21,94765.8%
20,4901,4577.1%Selling, general and administrative expenses: General and administrative22.7%
3,63324.0%
3,905(272)-7.0%23.7%
7,49323.5%
7,3031902.6% Marketing and selling33.7%
5,36625.8%
4,2001,16627.8%31.9%
10,02927.8%
8,6591,37015.8% Research and development9.5%
1,5138.6%
1,3931208.6%9.7%
3,0599.1%
2,8252348.3%Selling, general, and administrative expenses65.9%
10,51258.4%
9,4981,01410.7%65.4%
20,58160.4%
18,7871,7949.5% Other general and administrative expenses4.4%
6971.2%
193504261.1%4.0%
1,2521.0%
325927285.2%Total selling, general and administrative expenses70.3%
11,20959.6%
9,6911,51815.7%69.4%
21,83361.4%
19,1122,72114.2%Operating (loss) income-1.0%
(164)7.2%
1,170(1,334)-114.0%0.4%
1144.4%
1,378(1,264)-91.7%Other income (expense): Interest income0.0%
70.0%
5240.0%0.0%
70.1%
18(11)-61.1% Interest expense-0.4%
(67)-0.9%
(153)86-56.2%-0.5%
| SOURCE STAAR Surgical Company Copyright©2012 PR Newswire. All rights reserved |